跳至主要内容
临床试验/ISRCTN18035062
ISRCTN18035062进行中(未招募)Unknown

A feasibility and effectiveness trial to evaluate a digital intervention for the treatment of unipolar depression in adults

Elona Health GmbH0 个研究点目标入组 40 人开始时间: 2023年12月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All subjects must have been diagnosed with one of the following ICD-10 diagnoses:
  • F32.0: Mild depressive episode
  • F32.1: Moderate depressive episode
  • F32.2: Severe depressive episode
  • F33.0: Recurrent depressive disorder, current episode mild
  • F33.1: Recurrent depressive disorder, current episode moderate
  • F33.2: Recurrent depressive disorder, current episode severe
  • Subjects further need to:
  • 1. Be at least 18 years old
  • 2. Possess sufficient German language skills (in writing and reading)
  • 3. Possess a smartphone (iOS or Android operating system) with internet access
  • 4. Provide signed and dated informed consent and be willing to comply with the protocol

排除标准

  • All subjects without the inclusion ICD-10 diagnosis criteria, as well as subjects with the following ICD-10 diagnoses, are excluded:
  • F00-F09: Organic, including symptomatic, mental disorders
  • F10-F19 Mental and behavioural disorders due to psychoactive substance use (except F17.1, F17.2, F17.3)
  • F20-F29: Schizophrenia, schizotypal and delusional disorders
  • F30: Manic episode
  • F31.0, F31.1, F31.2, F31.5, F31.6, F31.8, F31.9: Bipolar disorder current hypomanic or manic episode
  • F32.3: Severe depressive episode with psychotic symptoms
  • F33.3: Recurrent depressive disorder, current episode severe with psychotic symptoms
  • 1. Subjects with acute suicidality (assessed via suicidality screening of the mini-DIPS at the initial screening)
  • 2. Subjects who are currently enrolled or are planning to participate in a potentially confounding drug or device trial during the study
  • 3. Subjects who are currently undergoing psychotherapy treatment (except consultation hours)
  • 4. Subjects who intend to discontinue or change the dose of a psychopharmacological medication currently being taken or start a new psychopharmacological treatment in the next 10 weeks
  • 5. Subjects who use another digital health application intended for mental health disorders
  • 6. Subjects under the age of 18 years, subjects without any access to a smartphone (iOS or Android operating system) with internet access
  • 7. Subjects without German language proficiency

研究者

发起方
Elona Health GmbH

相似试验

招募中
4 期
The Topical Trial: topical sevoflurane applied to chronic non-healing ulcer wounds for up to 30 daysChronic painful non-healing ulcersSkin - Other skin conditionsAnaesthesiology - Pain management
ACTRN12621001093875Anaesthetic Research Department, Waikato Hospital30
招募中
不适用
A clinical trial to evaluate the feasibility of patient-specific perigastric lymph node dissection (tailored surgery) using indocyanine green fluorescence navigation in gastric cancer surgeryDiseases of the digestive system
KCT0005760Seoul National University Hospital200
已完成
不适用
Clinical trial on the Feasibility and Efficacy of nab-PTX+GEM combination chemotherapy for elderly patients with advanced pancreatic cancerpancreatic cancer
JPRN-UMIN000018907Kitasato University School of Medicine25
尚未招募
2 期
A study to find the effectiveness of Sanjeevi Thailam (External-oil bath) and Plain Amukkara chooranam (Internal) with Sanjeevi Thailam(External-oil bath)in the management of Thookaminmai(Insomnia).
CTRI/2024/06/068776ational Institute of Siddha
进行中(未招募)
1 期
Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preemtive genotyping and pharmacogenetics training on the incidence of musculoskeletal adverse reactions in patients treated with statins in primary and specialized care.Cardiovascular risk which needs primary or secundary prevention with statinsMedDRA version: 21.0Level: LLTClassification code: 10020604Term: Hypercholesterolemia Class: 10027433MedDRA version: 20.0Level: PTClassification code: 10077965Term: Primary hypercholesterolaemia Class: 100000004850MedDRA version: 20.0Level: PTClassification code: 10020603Term: Hypercholesterolaemia Class: 100000004861
CTIS2023-506814-31-01Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa1,000